🔹 Revenue: $105.7B (Est. $103.63B) 🟢; +8.2% YoY
🔹 Adj. EPS: $1.09 (Est. $1.00) 🟢
🔹 Aetna: 95%+ of eligible prior authorizations approved within 24 hours
FY Guide:
🔹 Adj. EPS: $7.00–$7.20 (Est. $7.17) 🟡
🔹 GAAP EPS: $5.94–$6.14
🔹 Cash Flow from Ops: ≥ $9.0B
Financials:
🔹 Q4 Operating Income: $2.112B
🔹 Q4 Adj. Operating Income: $2.597B
🔹 Q4 Net Income: $2.923B
Commentary:
🔸 “Our fourth quarter and full-year results demonstrate the progress we are making in transforming the health care experience with our unique collection of businesses.”
🔸 “...we are well positioned to achieve our ambition to be the most trusted health care company in America.”